FDA Approval Summary: Enfortumab Vedotin plus Pembrolizumab for Cisplatin-Ineligible Locally Advanced or Metastatic Urothelial Carcinoma.
Maguire WF, Lee D, Weinstock C, Gao X, Bulik CC, Agrawal S, Chang E, Hamed SS, Bloomquist EW, Tang S, Pazdur R, Kluetz PG, Amiri-Kordestani L, Suzman DL.
Clin Cancer Res. 2024 May 15;30(10):2011-2016. doi: 10.1158/1078-0432.CCR-23-3738.
Impact of uptake time on image quality of [68 Ga]Ga-PSMA-11 PET/CT.
van der Sar ECA, Viol SLM, Braat AJAT, van Rooij R, Lam MGEH, de Jong HWAM, de Keizer B.
Med Phys. 2023 Dec;50(12):7619-7628. doi: 10.1002/mp.16429. Epub 2023 Apr 24.
A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naïve Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Bevacizumab in Urothelial Cancer.
McConkey DJ, Choi W, Shen Y, Lee IL, Porten S, Matin SF, Kamat AM, Corn P, Millikan RE, Dinney C, Czerniak B, Siefker-Radtke AO.
Eur Urol. 2016 May;69(5):855-62. doi: 10.1016/j.eururo.2015.08.034. Epub 2015 Sep 3.
Characterizing genetic interactions in human disease association studies using statistical epistasis networks.
Hu T, Sinnott-Armstrong NA, Kiralis JW, Andrew AS, Karagas MR, Moore JH.
BMC Bioinformatics. 2011 Sep 12;12:364. doi: 10.1186/1471-2105-12-364.
Proteomic and bioinformatic profiling of neutrophils in CLL reveals functional defects that predispose to bacterial infections.
Subramaniam N, Bottek J, Thiebes S, Zec K, Kudla M, Soun C, de Dios Panal E, Lill JK, Pfennig A, Herrmann R, Bruderek K, Rahmann S, Brandau S, Johansson P, Reinhardt HC, Dürig J, Seiffert M, Bracht T, Sitek B, Engel DR.
Blood Adv. 2021 Mar 9;5(5):1259-1272. doi: 10.1182/bloodadvances.2020002949.
First Evaluation of PET-Based Human Biodistribution and Dosimetry of 18F-FAZA, a Tracer for Imaging Tumor Hypoxia.
Savi A, Incerti E, Fallanca F, Bettinardi V, Rossetti F, Monterisi C, Compierchio A, Negri G, Zannini P, Gianolli L, Picchio M.
J Nucl Med. 2017 Aug;58(8):1224-1229. doi: 10.2967/jnumed.113.122671. Epub 2017 Feb 16.
Validation of Prognostic Scores in Patients With Metastatic Urothelial Cancer Enrolling in Phase I Targeted Therapy or Next Generation Immunotherapy Trials.
Alhalabi O, Hahn AW, Msaouel P, Meric-Bernstam F, Wilson N, Naing A, Piha-Paul S, Janku F, Pant S, Yap TA, Hong DS, Fu S, Karp D, Beltran K, Campbell E, Le H, Campbell MT, Shah A, Tannir NM, Siefker-Radtke A, Gao J, Roszik J, Subbiah V.
Clin Genitourin Cancer. 2022 Feb;20(1):e16-e24. doi: 10.1016/j.clgc.2021.07.004. Epub 2021 Jul 12.
Recurring multifocal leiomyosarcoma of the urinary bladder 22 years after therapy for bilateral (hereditary) retinoblastoma: a case report and review of the literature.
Svajdler M Jr, Andrašina I, Ilenčíková D, Rychlý B, Piačková B.
Cesk Patol. 2012 Jan;48(1):44-8.
Chronic hepatitis C virus infection and genitourinary cancers: A case-control study.
Angelidakis G, Mahale P, Jonasch E, Jiang Y, Torres HA.
Semin Oncol. 2020 Apr-Jun;47(2-3):165-167. doi: 10.1053/j.seminoncol.2020.04.005. Epub 2020 May 21.
Muir-Torre syndrome: a case of this uncommon entity.
Weinstein A, Nouri K, Bassiri-Tehrani S, Flores F, Jimenez G.
Int J Dermatol. 2006 Mar;45(3):311-3. doi: 10.1111/j.1365-4632.2006.01797.x.
